When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

With a 31.1% gain, 2024 has proven to be my most successful investing year. Read more to see what I expect from 2025.

A clinical trial has backed the safety and efficacy of one of Novo Nordisk's weight-loss medicines in children as young as six, showing a significant drop in body mass index (BMI). The study used ...

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. The Danish drugmaker has acquired exclusive rights outside ...

Twins are pretty rare, accounting for just 3% of births in the U.S. these days. But new research shows that for primates 60 million years ago, giving birth to twins was the norm.

As Bulgaria joined Europe's borderless travel zone on January 1st, Greeks have been freely flocking to the neighboring country, where petrol prices are cheaper, to fill up their tanks. Bulgaria, along ...